Migraine affects roughly 39 million Americans, and for those with moderate-to-severe attacks, Nurtec ODT (rimegepant) has become a game-changer — the first medication FDA-approved for both acute treatment and prevention of episodic migraine in a single pill. Dissolving on the tongue without water, it’s convenient, effective, and has a favorable side effect profile compared with older triptans. But the Nurtec cost is a significant barrier: $900 to $1,100 per month without insurance for preventive dosing, or roughly $100 per tablet for acute use. Understanding your options for reducing that price is critical to sustaining treatment. For broader strategies on managing medication expenses, see our healthcare costs guide.
Nurtec Retail Pricing Without Insurance
Nurtec ODT is manufactured by Pfizer (following its acquisition of Biohaven Pharmaceuticals) and comes as 75 mg orally disintegrating tablets. The medication has two FDA-approved uses — acute migraine treatment (one tablet as needed at onset) and preventive therapy (one tablet every other day). Pricing depends on the quantity prescribed:
- 8 tablets (acute use, one month supply): $900 to $1,050 at retail pharmacies
- 15 tablets (preventive use, one month supply of every-other-day dosing): $950 to $1,100
- Per-tablet cost: approximately $70 to $110
Cash prices at major chains (CVS, Walgreens, Walmart) cluster around $950 to $1,050 for either prescription quantity. Independent and online pharmacies occasionally offer modestly lower pricing. These figures make Nurtec one of the more expensive oral migraine medications, though it’s priced similarly to other CGRP receptor antagonists like Ubrelvy (ubrogepant, acute only) and injectable CGRP antibodies like Aimovig and Ajovy.
Brand vs. Generic: Is a Cheaper Version Available?
No generic rimegepant is available as of early 2026. Pfizer holds patent protections on Nurtec that are expected to prevent generic entry until at least the late 2020s, though exact timelines depend on patent litigation outcomes.
Within the CGRP class, there are no generic alternatives. The competitive landscape includes Ubrelvy (ubrogepant) for acute treatment only, priced similarly at $900 to $1,100 per month; Qulipta (atogepant) for prevention only, at roughly $900 to $1,000 per month; and injectable CGRP antibodies (Aimovig, Ajovy, Emgality) at $600 to $700 per monthly injection. Outside the CGRP class, generic triptans (sumatriptan at $10 to $40 for 9 tablets) remain the most affordable acute migraine treatment, and generic topiramate or propranolol ($10 to $30 per month) are commonly used for prevention.
The Mayo Clinic notes that CGRP medications like Nurtec are typically reserved for patients who have not responded to or cannot tolerate triptans and other first-line treatments. Your neurologist will consider your treatment history, migraine frequency, and insurance coverage when recommending the most appropriate option.
Nurtec Cost With Insurance
Most commercial insurance plans cover Nurtec, but formulary placement varies. Common scenarios include Tier 3 (preferred brand) placement with copays of $40 to $75 per fill, Tier 4 (specialty brand) with copays of $75 to $200 or coinsurance of 25% to 50%, and quantity limits that restrict the number of tablets per month (commonly 8 for acute use or 15 for preventive use).
Prior authorization is nearly universal. Insurers typically require documentation that the patient meets diagnostic criteria for migraine (ICHD-3 classification), has tried and failed at least two generic preventive medications (for preventive Nurtec) or two triptans (for acute Nurtec), and has a migraine frequency that justifies the specific indication. The process can take 5 to 15 business days, so ask your neurologist to initiate prior authorization before your current treatment runs out.
Medicare Part D covers Nurtec on most formularies. Medicare beneficiaries should be aware that specialty-tier placement can mean coinsurance of 25% to 33%, though the Inflation Reduction Act’s $2,000 annual out-of-pocket cap (effective 2025) limits total drug spending. For someone taking Nurtec alone at $1,000/month, the annual cap would be reached within the first two to three months, after which further fills are covered at no additional cost for the remainder of the year.
Pfizer’s Nurtec Savings Programs
Pfizer offers a copay savings card for Nurtec that is among the most generous in the pharmaceutical industry. Eligible commercially insured patients can pay as little as $0 per prescription, with the program covering copays up to an annual maximum (typically $13,200 per year, which effectively covers the full copay for every fill).
Eligibility requires commercial insurance that covers Nurtec, a valid prescription, US residency, and no enrollment in Medicare, Medicaid, Tricare, or other government programs. The savings card can be obtained through the Nurtec website, your neurologist’s office, or the specialty pharmacy filling your prescription. Activation is straightforward — most patients have it applied at the pharmacy counter during their first fill.
Beware of copay accumulator programs. Some insurers do not count manufacturer copay card payments toward your annual deductible or out-of-pocket maximum. In these cases, you could reach the end of the copay card’s annual benefit without having advanced toward your plan’s cap, leaving you exposed to the full cost for subsequent fills. Ask your insurer directly: “Does manufacturer copay assistance count toward my deductible and out-of-pocket maximum?”
Patient Assistance for Uninsured or Medicare Patients
Pfizer’s Patient Assistance Program provides Nurtec at no cost to qualifying patients who lack prescription drug coverage or whose coverage does not include Nurtec. Income eligibility is generally set at or below 400% of the federal poverty level (approximately $62,000 for a single individual in 2026). The application requires proof of income, insurance status documentation, and a prescriber’s signature.
Additional resources include the NeedyMeds database, which lists all available assistance for rimegepant; the American Migraine Foundation’s resource directory; and state pharmaceutical assistance programs (SPAPs) that some states operate for residents who fall into coverage gaps. The Partnership for Prescription Assistance can help match you with the right program.
For Medicare Part D patients specifically, Pfizer’s copay card cannot be used, but the patient assistance program accepts applications from Medicare beneficiaries who face financial hardship. Additionally, Medicare’s Extra Help (Low-Income Subsidy) program can reduce Part D premiums, deductibles, and copays for qualifying individuals.
Understanding the Total Cost of Migraine Care
Nurtec’s sticker price should be evaluated in the context of migraine’s total economic burden. The American Migraine Foundation estimates that migraine costs the US economy over $36 billion annually in direct medical expenses, lost workdays, and reduced productivity. Individual migraine sufferers spend an average of $8,500 to $9,500 per year on migraine-related healthcare, including medications, doctor visits, ER visits, and lost wages.
For patients with frequent migraines (8 or more headache days per month), effective prevention with Nurtec can reduce the number of migraine days by 3 to 4 per month, based on clinical trial data. If each avoided migraine day saves $200 to $300 in productivity and acute treatment costs, the annual savings ($7,200 to $14,400) can exceed the medication cost — before factoring in the quality-of-life improvements that come with fewer debilitating attacks.
The ER is particularly expensive for migraine. An ER visit for migraine averages $1,500 to $3,000 according to CMS data, and patients with poorly controlled migraines average 1 to 3 ER visits per year. Effective preventive therapy like Nurtec can substantially reduce ER utilization, a factor that health economists weigh when assessing cost-effectiveness.
Pharmacy Discount Cards and Savings Strategies
GoodRx, RxSaver, and SingleCare offer coupons for Nurtec that typically reduce the cash price to $750 to $900 per fill — a savings of $100 to $200 compared with the retail cash price, but still substantial out-of-pocket for most patients. Discount cards are most useful for patients who lack insurance entirely or whose plan does not cover Nurtec after a prior authorization denial.
For most insured patients, the manufacturer copay card provides deeper savings than any discount platform. The optimal strategy is: first, confirm insurance coverage and copay; second, apply the Pfizer copay card to reduce or eliminate the copay; third, if the copay card is declined or insurance doesn’t cover Nurtec, compare GoodRx pricing against the retail cash price. Always use the option that produces the lowest out-of-pocket cost — your pharmacist can run both options through the system before processing.
Frequently Asked Questions
Is Nurtec covered by most insurance plans?
Yes, most major commercial insurance plans and Medicare Part D formularies include Nurtec, though typically on a specialty or non-preferred brand tier. Prior authorization is almost always required, and some plans impose quantity limits or step therapy requirements. Check your plan’s formulary before assuming coverage, and work with your neurologist’s office to handle prior authorization.
Can I use the Nurtec copay card with Medicare?
No. Federal law prohibits manufacturers from providing copay assistance to Medicare, Medicaid, and other government program beneficiaries. Medicare patients should apply for Pfizer’s Patient Assistance Program or explore Medicare’s Extra Help program for low-income beneficiaries. The Inflation Reduction Act’s $2,000 out-of-pocket cap also limits Medicare exposure.
Is Nurtec worth the cost compared with triptans?
For patients who respond well to triptans, the cost difference is hard to justify — generic sumatriptan costs $10 to $40 per month. Nurtec’s value proposition is strongest for patients who don’t respond to triptans, experience intolerable triptan side effects (chest tightness, nausea, fatigue), have cardiovascular contraindications to triptans, or need a combined acute/preventive medication. Discuss the clinical and financial trade-offs with your neurologist.
Can I take Nurtec for both prevention and acute treatment?
Yes, and this dual-use approval is unique among CGRP medications. For prevention, you take 75 mg every other day on a scheduled basis. For acute treatment, you take 75 mg at migraine onset. Some patients use it for both — preventing on a regular schedule and treating breakthrough attacks. Your neurologist will determine the most appropriate dosing strategy based on your migraine pattern.
What to Do Next
If your neurologist has recommended Nurtec, start the prior authorization process immediately — delays can leave you without medication during the approval window. Activate the Pfizer copay card before your first fill if you have commercial insurance. If you’re uninsured or on Medicare, apply for the patient assistance program right away, and ask your doctor for samples to bridge you through the application period.
Keep a migraine diary tracking frequency, severity, and response to treatment — this data strengthens future prior authorization renewals and helps your neurologist optimize your care plan. If a prior authorization is denied, appeal immediately; denial rates for CGRP medications are high on first pass but reversal rates on appeal are also substantial. Your neurologist’s office likely has experience with these appeals and can guide the process. The gap between Nurtec’s list price and what you actually pay can be enormous with the right programs in place — often the difference between $1,000 per month and $0.